BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25049160)

  • 1. [Mesothelioma staging with ¹⁸F-FDG PET/CT. A case report with simultaneous pleural and peritoneal infiltration].
    Moreno C; Soler M; Mourelo S; Moragas M; Riera E; Garcia JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):141-2. PubMed ID: 25049160
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.
    Roca E; Laroumagne S; Vandemoortele T; Berdah S; Dutau H; Maldonado F; Astoul P
    Lung Cancer; 2013 Feb; 79(2):187-90. PubMed ID: 23206832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG imaging of malignant pleural mesothelioma: scientiam impendere vero..
    Gerbaudo VH
    Nucl Med Commun; 2003 Jun; 24(6):609-14. PubMed ID: 12766595
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy].
    Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Hernández Pérez R; Hualde AM; Pérez Aradas V
    Rev Esp Med Nucl; 2011; 30(5):307-10. PubMed ID: 21641092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET/CT in the management of primary pleural tumors and pleural metastases.
    Kruse M; Sherry SJ; Paidpally V; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2013 Aug; 201(2):W215-26. PubMed ID: 23883236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
    Sun Y; Yu H; Ma J; Lu P
    PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
    Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.
    Kitajima K; Doi H; Kuribayashi K
    Jpn J Radiol; 2016 Aug; 34(8):537-47. PubMed ID: 27222020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal stromal tumour with unusual sites of metastasis: accurate staging with ¹⁸F-FDG PET/CT.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):60-1. PubMed ID: 25263720
    [No Abstract]   [Full Text] [Related]  

  • 12. Histology of the pleural rind at [
    Soltermann A; Opitz I; Burger IA
    Pathol Res Pract; 2021 Dec; 228():153660. PubMed ID: 34749212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
    Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST
    J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of Malignant Pleural, Pericardial, and Peritoneal Mesothelioma.
    Strange CD; Marom EM; Ahuja J; Shroff GS; Gladish GW; Carter BW; Truong MT
    Adv Anat Pathol; 2023 Jul; 30(4):280-291. PubMed ID: 36395181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenteric lipogranuloma mimicking malignancy at ¹⁸F-FDG PET/CT in a patient with colon cancer.
    Treglia G; Rusca-Fadda T; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):56-7. PubMed ID: 24986550
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
    Ng DC; Hain SF; O'Doherty MJ; Dussek J
    J Nucl Med; 2000 Aug; 41(8):1443-4. PubMed ID: 10945542
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of FDG PET-CT in differential diagnosis of pleural pathologies.
    Elboga U; Yılmaz M; Uyar M; Zeki Çelen Y; Bakır K; Dikensoy O
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):187-91. PubMed ID: 23067687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eComment: What is the best way to diagnose and stage malignant pleural mesothelioma?
    Cafarotti S; Porziella V; Margaritora S; Granone P
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):811. PubMed ID: 21555444
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Elliott HS; Metser U; de Perrot M; Cho J; Bradbury P; Veit-Haibach P; Hussey D; Noam T
    Br J Radiol; 2018 Jun; 91(1086):20170814. PubMed ID: 29498536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.